Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Dev Neurosci. 2013;35(2-3):140-54. doi: 10.1159/000350230. Epub 2013 Apr 20.
Oxidative stress involving premyelinating oligodendrocytes (OLs) is a major factor in the pathogenesis of preterm white matter injury. In animal and cell culture studies, activation of the lipid-oxidizing enzyme 12/15-lipoxygenase (12/15-LOX) plays a central role as an inflammatory mediator in the pathology of oxidative stress and OL cell death, as well as ischemia and neuronal death. The role of 12/15-LOX, however, is unclear in the developing human brain. The mechanism of 12/15-LOX involves the production of reactive oxygen species through the metabolism of arachidonic acid, as well as direct detrimental effects on organelle membranes. Here we tested the hypothesis that the density of 12/15-LOX-expressing cells is increased in periventricular leukomalacia (PVL). Using immunocytochemistry (ICC) in human paraffin-embedded tissue, 12/15-LOX expression was seen in macrophages of the focally necrotic lesions in the periventricular white matter, as well as in glial cells throughout the surrounding white matter with reactive gliosis. Interestingly, no significant 12/15-LOX expression was detected in neurons in the cerebral cortex overlying the damaged white matter. Using a scoring system from 0 to 3, we assessed the density of 12/15-LOX-expressing cells in diffusely gliotic white matter from 20 to 43 postconceptional (PC) weeks in 19 PVL cases (median = 36 PC weeks) and 10 control (non-PVL) cases (median = 34 PC weeks). The density of 12/15-LOX-positive cells was significantly increased in the diffuse component of PVL (score = 1.17 ± 0.15) compared to controls (score = 0.48 ± 0.21; p = 0.014). Using double-label ICC, 12/15-LOX was observed in PVL in OLs of the O4 and O1 premyelinating stages, as well as in mature OLs as determined with the mature OL marker adenomatous polyposis coli (APC). In addition, 12/15-LOX expression was present in a population of CD68-positive activated microglia. There was no 12/15-LOX expression in reactive astrocytes. Finally we observed terminal deoxynucleotide transferase dUTP nick end-labeling-positive cells within the white matter of PVL that expressed 12/15-LOX and/or within close proximity of 12/15-LOX-positive cells. Our data support a role for 12/15-LOX activation as an inflammatory mediator of injury in PVL, with a contribution of 12/15-LOX to PVL-induced damage to or cell death of OLs, including those at the O1 and O4 stages.
涉及少突胶质前体细胞(OLs)的氧化应激是早产儿脑白质损伤发病机制中的一个主要因素。在动物和细胞培养研究中,脂质氧化酶 12/15-脂氧合酶(12/15-LOX)的激活作为一种炎症介质,在氧化应激和 OL 细胞死亡、以及缺血和神经元死亡的病理学中发挥核心作用。然而,12/15-LOX 在发育中的人类大脑中的作用尚不清楚。12/15-LOX 的机制涉及通过花生四烯酸的代谢产生活性氧,以及对细胞器膜的直接有害影响。在这里,我们检验了这样一个假设,即在脑室周围白质软化症(PVL)中,表达 12/15-LOX 的细胞密度增加。使用人石蜡包埋组织中的免疫细胞化学(ICC),在脑室周围白质局灶性坏死病变的巨噬细胞中以及在整个周围白质的反应性神经胶质细胞中观察到 12/15-LOX 的表达。有趣的是,在损伤白质上方的大脑皮质的神经元中未检测到明显的 12/15-LOX 表达。使用从 0 到 3 的评分系统,我们评估了 19 例 PVL 病例(中位数=36 孕龄周)和 10 例对照(非-PVL)病例(中位数=34 孕龄周)弥漫性神经胶质增生的白质中表达 12/15-LOX 的细胞密度。与对照组(评分=0.48±0.21;p=0.014)相比,PVL 弥漫性成分中 12/15-LOX 阳性细胞的密度明显增加(评分=1.17±0.15)。使用双标记 ICC,在 O4 和 O1 前髓鞘化阶段的 OLs 以及用成熟 OL 标志物 APC 确定的成熟 OL 中观察到 PVL 中的 12/15-LOX。此外,12/15-LOX 表达存在于一群 CD68 阳性活化的小胶质细胞中。反应性星形胶质细胞中没有 12/15-LOX 表达。最后,我们在 PVL 的白质内观察到表达 12/15-LOX 和/或与 12/15-LOX 阳性细胞接近的末端脱氧核苷酸转移酶 dUTP 缺口末端标记阳性细胞。我们的数据支持 12/15-LOX 激活作为 PVL 中损伤的炎症介质的作用,12/15-LOX 对 PVL 诱导的 OL 损伤或细胞死亡有一定作用,包括 O1 和 O4 阶段的 OL。